A detailed history of Franklin Resources Inc transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 72,653 shares of MRVI stock, worth $379,248. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72,653
Holding current value
$379,248
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$6.84 - $9.73 $496,946 - $706,913
72,653 New
72,653 $603,000
Q3 2023

Nov 13, 2023

BUY
$9.14 - $12.85 $27,072 - $38,061
2,962 Added 28.16%
13,481 $134,000
Q2 2023

Aug 11, 2023

BUY
$12.09 - $15.0 $127,174 - $157,785
10,519 New
10,519 $130,000
Q4 2022

Feb 10, 2023

SELL
$12.5 - $24.78 $391,175 - $775,465
-31,294 Reduced 74.79%
10,548 $150,000
Q3 2022

Nov 14, 2022

SELL
$20.6 - $30.37 $148,958 - $219,605
-7,231 Reduced 14.74%
41,842 $1.07 Million
Q2 2022

Aug 11, 2022

BUY
$26.05 - $37.48 $63,588 - $91,488
2,441 Added 5.23%
49,073 $1.39 Million
Q1 2022

May 13, 2022

SELL
$24.46 - $40.92 $26.1 Million - $43.6 Million
-1,065,136 Reduced 95.81%
46,632 $1.64 Million
Q4 2021

Feb 11, 2022

SELL
$35.0 - $45.94 $54.4 Million - $71.4 Million
-1,553,515 Reduced 58.29%
1,111,768 $46.6 Million
Q3 2021

Nov 12, 2021

SELL
$36.8 - $60.62 $7.67 Million - $12.6 Million
-208,454 Reduced 7.25%
2,665,283 $131 Million
Q2 2021

Aug 13, 2021

BUY
$32.46 - $45.0 $20.6 Million - $28.5 Million
633,195 Added 28.26%
2,873,737 $120 Million
Q1 2021

May 13, 2021

BUY
$25.8 - $38.49 $10.1 Million - $15.1 Million
391,137 Added 21.15%
2,240,542 $79.9 Million
Q4 2020

Feb 10, 2021

BUY
$24.5 - $30.86 $45.3 Million - $57.1 Million
1,849,405 New
1,849,405 $51.9 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $687M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.